--(BUSINESS WIRE)--Allele Biotech (Allele) focuses on innovative research in life sciences. Allele has become a reliable source for superior fluorescent proteins (available for licensing to pharmaceutical companies), highly efficient Luciferase substrates, and genotyping kits. After the recent acquisition of Orbigen, Inc., Allele now offers Baculovirus protein expression and Phoenix retrovirus systems. Allele also continues to be a leader in the RNAi field. The recent patents on Pol III promoters expressing shRNA or miRNA allow Allele’s industry customers certain freedom to operate in using RNAi through Allele.
